Sources of Bioburden You Might Have Missed
May 4, 2017 - Cytiva

A problem with traditional mAb manufact

Witnessing Major Growth in Next-Generation Antibodies
May 4, 2017 - BioPharm Intl.

Including next-gen antibodies in pharma pipelines is considered essential for future success.

By Cynthia A. Challener

Being Thorough When Transferring Technology
May 4, 2017 - BioPharm Intl.

Communication and taking the time to develop the process are key to successful transfer and scale up of biologics.

By Susan Haigney

Improvements in Protein A Chromatography
May 4, 2017 - Process Development Forum

Process Development Forum speaks about Protein A chromatography with Glen Bolton, Scientific Director at Amgen. Bolton recently published a pap

HTPD: Optimizing a mAb Chromatography Polishing Step
April 19, 2017 - Cytiva

Development of robust purification processes requires s

Mechanistic Modeling of Preparative Ion-Exchange Chromatography
April 19, 2017 - BioPharm Intl.

By Anurag Rathore, Vijesh Kumar

Downstream Processing for Cell-Based Therapies
April 19, 2017 - BioPharm Intl.

By Qasim A. Rafiq, Fernanda Masri

Critical Quality Attributes Challenge Biologics Development
April 19, 2017 - BioPharm Intl.

The complex nature of biologics adds additional CQAs that must be determined to ensure the safe development of biologics.

By Susan H

Speed and Flexibility Are Dual Goals for Biopharma Operations
April 7, 2017 - Product Development Forum

Bioprocessing facilities, equipment, and materials, as well as strategies to improve biopharmaceutical development and manufacturing, were featured at I

Accelerated flavivirus vaccine production with modern tools and s


April 6, 2017 - Cytiva

Flavivirus vaccine development and production constitute many c

Previous PageNext Page